itraconazole has been researched along with albendazole in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canning, EU; Curry, A | 1 |
Leitch, GJ; Scanlon, M; Shaw, A; Visvesvara, GS; Wallace, S | 1 |
Cheng, J; Cun, D; Fang, L; Li, W; Liu, J; Quan, P; Xiang, R; Zhang, Y | 1 |
Bai, L; Mai, HA; Wang, YH; Zhao, JM | 1 |
Garg, B; Goyal, RC; Mishra, A; Sood, N; Tyagi, R | 1 |
Ahnn, J; Cho, JH; Choi, TW; Song, HO | 1 |
Bergström, CA; Hubatsch, I; Johansson, K; Wassvik, CM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for itraconazole and albendazole
Article | Year |
---|---|
Human microsporidiosis.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Eye Infections, Parasitic; Humans; Intestinal Diseases, Parasitic; Itraconazole; Microsporida; Microsporidiosis | 1993 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for itraconazole and albendazole
Article | Year |
---|---|
Use of a fluorescent probe to assess the activities of candidate agents against intracellular forms of Encephalitozoon microsporidia.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Cyclohexanes; Encephalitozoon; Fatty Acids, Unsaturated; Fluoresceins; Fluorescent Dyes; Itraconazole; Kidney; Metronidazole; Microscopy, Confocal; Sesquiterpenes | 1997 |
Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions.
Topics: 1-Octanol; Absorption; Albendazole; Animals; Biological Availability; Calorimetry, Differential Scanning; Fenofibrate; Itraconazole; Male; Microscopy, Electron, Scanning; Nanoparticles; Pharmaceutical Preparations; Powder Diffraction; Probucol; Pyrimidinones; Rats; Rats, Wistar; Solubility; Surface Properties; Suspensions; Tetrahydroisoquinolines; Transition Temperature; Water; X-Ray Diffraction | 2014 |
[Effect of different drugs on Echinococcus multilocularis metacestodes in vitro ].
Topics: Albendazole; Animals; Anticestodal Agents; Drug Therapy, Combination; Echinococcosis; Echinococcus multilocularis; Female; Gerbillinae; Hep G2 Cells; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Nitro Compounds; Thiazoles | 2011 |
Pulmonary Hydatid Disease with Aspergillosis - An Unusual Association in an Immunocompetent Host.
Topics: Albendazole; Anticestodal Agents; Antifungal Agents; Echinococcosis, Pulmonary; Humans; Immunocompetence; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Thoracic Surgery, Video-Assisted | 2019 |
Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery.
Topics: Albendazole; Amino Acid Sequence; Animals; Antinematodal Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium-Binding Proteins; Diethylcarbamazine; Drug Discovery; Drug Evaluation, Preclinical; Filariasis; Itraconazole; Ivermectin; Models, Molecular; Quantitative Structure-Activity Relationship | 2018 |
Poorly soluble marketed drugs display solvation limited solubility.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Principal Component Analysis; Solubility; Tandem Mass Spectrometry; Thermodynamics | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |